exa-cel
Vertex pharmaceuticals,CRISPR therapeutics AG
[]
1/ announce presentation of new data on exa-cel, formerly ctx001, from 75 patients - 44 tdt + 31 scd &amp; with follow-up of up to 37.2 months. the data demonstrates that exa-cel has the potential to be a one-time functional #cure $crsp #eha2022 #geneediting #crispr #biotech 
#Science - First and Foremost. Special interest in #CRISPR, #GeneEditing, #GeneTherapy ?? & #Ophthalmology. #Biotech, #Markets & #Stocks ??